General AML

Prof. Richard Stone | EBMT 2018 | What are the latest advances in monitoring MRD in AML?


At the 44th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting, 18–21 Mar 2018, Lisbon, PT,  Prof. Richard Stone from the Dana-Farber Cancer Institute, Boston, US, discusses the different methods of detecting MRD in acute myeloid leukemia (AML) including multiparameter flow cytometry (MFC) and real-time quantitative polymerase chain reaction (RQ-PCR) and also the use of the data obtained from these analysis. 

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF